Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, to deliver the 5th in VHIO´s prestigious series of VHIO Meet the Editors talks:
Cancer Cell and the Cancer Research Community
Related Posts
´Live´breast cancer biobank to accelerate more precise testing of experimental anti-cancer medicines
• High-throughput mass screening platform to spur drug development in breast cancer by testing response to over 100 anti-cancer agents…
19 Sep 2016
VHIO´s Josep Tabernero awarded the Josep Trueta Medal for his outstanding contribution to advancing healthcare
Officially announced yesterday, the Government of the Generalitat of Catalonia has revealed the thirteen recipients of the Josep Trueta Medal…
14 Dec 2016
Date in the diary with Nature Reviews Cancer 29 June 15:00h – 16:15h
Taking place on Monday 29 June 2015, 15:00 – 16:15, we are delighted to announce that Senior Editor of Nature Reviews Cancer,…
15 Jun 2015
Driving a novel therapy against glioblastoma: VHIO´s Laura Soucek awarded BBVA Foundation Grant to validate peptides targeting Myc
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
09 Oct 2015
Calling Young Scientists: deadline extended to 04 August to apply for EurocanPlatform´s Translational Cancer Research Course, 20 – 24 October 2014, Portugal
Aimed at exploring all aspects of the translational research continuum, from early detection through treatment to survivorship, this special 5-day…
10 Jul 2014
Laura Soucek awarded prestigious AICR grant to develop anti-cancer therapies through Myc inhibtion
The Association for International Cancer Research (AICR) – now rebranded as Worldwide Cancer Research – has awarded one of its prestigious…
03 Jun 2013
VHIO on the ground presenting at this year´s ASCO Annual Meeting: a hand-pick of highlights
Many of VHIO´s leading clinical investigators are currently participating at the 2017 Annual Meeting of the American Society of Clinical…
03 Jun 2017
VHIO to lead phase II combination study to assess efficacy of novel anticancer agent against endometrial cancer
Announced today by Catalan biopharmaceutical company, Ability Pharmaceuticals SL, VHIO has been selected to lead a phase II clinical trial…
23 Nov 2016
The Spanish Association Against Cancer (AECC): spurring VHIO research and improved therapeutic strategies against cancer
Barcelona, September 15, 2015– We can only hope to collectively accelerate the pace in advancing more precisely targeted therapies against…
16 Sep 2015
Oncology channel ecancer catches up with VHIO´s Elena Garralda and Cristina Saura during last week´s ESMO Congress
During last week´s ESMO Congress celebrated in Madrid 08 – 12 September, oncology channel ecancer TV interviewed Elena Garralda, Executive…
14 Sep 2017
Latest research unmasks six new susceptibility genes predisposing to ovarian cancer
Ovarian cancer ranks fifth among cancer-related death in women. While the exact cause of ovarian cancer remains largely unknown, up…
05 Feb 2015
Genomic analysis of different brain metastases reveals common mutations that could promise viable therapeutic targets
• An international study, published in the journal Cancer Discovery, in which the Vall d’Hebron University Hospital and the Vall…
27 Sep 2015
In partnership with leading organisations across the globe AECC declares 24 September as World Cancer Research Day
Today, a special roundtable, presided by Her Majesty Queen Letizia of Spain, President of the Spanish Association Against Cancer (AECC),…
22 Sep 2016
Last chance to register: VHIO´s Meet the Editors with Nature Medicine
Nature Medicine´s Senior Editor, Victoria Aranda, will come to VHIO Monday 17 September 2012 to deliver the 4th in the…
04 Sep 2012
